Overview

Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)

Status:
Completed
Trial end date:
2001-02-01
Target enrollment:
Participant gender:
Summary
A study of Montelukast compared to placebo in asthmatic children aged 6-24 months.
Phase:
N/A
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast